499 related articles for article (PubMed ID: 16426893)
1. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
[TBL] [Abstract][Full Text] [Related]
2. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
[TBL] [Abstract][Full Text] [Related]
3. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation.
Bès C; Cerutti M; Briant-Longuet L; Bresson D; Peraldi-Roux S; Pugnière M; Mani JC; Pau B; Devaux C; Granier C; Devauchelle G; Chardès T
Hum Antibodies; 2001; 10(2):67-76. PubMed ID: 11673661
[TBL] [Abstract][Full Text] [Related]
4. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
5. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
Chen FL; Kung JT
J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
[TBL] [Abstract][Full Text] [Related]
6. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
[TBL] [Abstract][Full Text] [Related]
7. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
[TBL] [Abstract][Full Text] [Related]
8. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis.
Guillerm C; Robert-Hebmann V; Hibner U; Hirn M; Devaux C
Virology; 1998 Sep; 248(2):254-63. PubMed ID: 9721234
[TBL] [Abstract][Full Text] [Related]
9. The lipid-modulating effects of a CD4-specific recombinant antibody correlate with ZAP-70 segregation outside membrane rafts.
Chentouf M; Rigo M; Ghannam S; Navarro-Teulon I; Mongrand S; Pèlegrin A; Chardès T
Immunol Lett; 2010 Oct; 133(2):62-9. PubMed ID: 20659502
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
11. An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p56lck-negative HTLV-I-transformed cell line.
Lemasson I; Briant L; Hague B; Coudronnière N; Heron L; David C; Rebouissou C; Kindt T; Devaux C
J Immunol; 1996 Jan; 156(2):859-65. PubMed ID: 8543843
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of anti-CD4-induced T helper cell depletion and inhibition of function. Activation of T cells by the CD3 pathway inhibits anti-CD4-mediated T cell elimination and down-regulation of cell surface CD4.
Jamali I; Field EH; Fleming A; Cowdery JS
J Immunol; 1992 Mar; 148(6):1613-9. PubMed ID: 1347302
[TBL] [Abstract][Full Text] [Related]
13. CD4-mediated signals induce T cell dysfunction in vivo.
Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside control over IL-4 priming and cytokine production in activated T cells.
Chen XP; Ding X; Daynes RA
Cytokine; 2000 Jul; 12(7):972-85. PubMed ID: 10880242
[TBL] [Abstract][Full Text] [Related]
15. PIN-bodies: a new class of antibody-like proteins with CD4 specificity derived from the protein inhibitor of neuronal nitric oxide synthase.
Bès C; Troadec S; Chentouf M; Breton H; Lajoix AD; Heitz F; Gross R; Plückthun A; Chardès T
Biochem Biophys Res Commun; 2006 Apr; 343(1):334-44. PubMed ID: 16540093
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
[TBL] [Abstract][Full Text] [Related]
17. Vomitoxin-mediated IL-2, IL-4, and IL-5 superinduction in murine CD4+ T cells stimulated with phorbol ester calcium ionophore: relation to kinetics of proliferation.
Ouyang YL; Azcona-Olivera JI; Murtha J; Pestka JJ
Toxicol Appl Pharmacol; 1996 Jun; 138(2):324-34. PubMed ID: 8658534
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.
Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR
Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231
[TBL] [Abstract][Full Text] [Related]
19. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication by a monoclonal antibody directed toward the complementarity determining region 3-like domain of CD4 in CD45 expressing and CD45-deficient cells.
Péléraux A; Peyron JF; Devaux C
Virology; 1998 Mar; 242(1):233-7. PubMed ID: 9501032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]